TransBiotec, Inc. (IMLE)

Sorry, no known transcripts

Recent filings

TransBiotec: Sobrsafe Announces Pricing Of $10 Million Public Offering And Uplisting To The Nasdaq Capital Market - May 19, 2022

TransBiotec, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - May 17, 2022

Notification of inability to timely file Form 10-Q or 10-QSB - May 17, 2022

Certification by an exchange approving securities for listing - May 13, 2022

Registration of securities [Section 12(b)] - May 13, 2022

General form for registration of securities under the Securities Act of 1933 - May 12, 2022

Filing under Securities Act Rules 163/433 of free writing prospectuses - May 10, 2022

General form for registration of securities under the Securities Act of 1933 - May 6, 2022

Filing under Securities Act Rules 163/433 of free writing prospectuses - April 21, 2022

Filing under Securities Act Rules 163/433 of free writing prospectuses - April 8, 2022

General form for registration of securities under the Securities Act of 1933 - April 8, 2022

General form for registration of securities under the Securities Act of 1933 - April 4, 2022

Entry into a Material Definitive - April 1, 2022

General form for registration of securities under the Securities Act of 1933 - March 17, 2022

TransBiotec, Inc. Just Filed Its Annual Report: Basic net loss per s... - March 11, 2022

General form for registration of securities under the Securities Act of 1933 - Feb. 11, 2022

TransBiotec, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 11, 2022

General form for registration of securities under the Securities Act of 1933 - Feb. 1, 2022

General form for registration of securities under the Securities Act of 1933 - Jan. 19, 2022

General form for registration of securities under the Securities Act of 1933 - Dec. 20, 2021

Revised definitive proxy soliciting materials - Dec. 15, 2021

General form for registration of securities under the Securities Act of 1933 - Dec. 7, 2021

TransBiotec, Inc. releases salary data. CEO sees compensation fall -24% - Nov. 24, 2021

TransBiotec, Inc. Just Filed Its Quarterly Report: Basic net loss per s... - Nov. 15, 2021

Other preliminary proxy statements - Nov. 8, 2021

General form for registration of securities under the Securities Act of 1933 - Nov. 2, 2021

TransBiotec: Forges Partnership With Leading Healthcare Fund Boulder, CO, - Oct. 1, 2021

TransBiotec: Sobrsafe Secures $3.0 Million Financing From Leading Healthcare Fund Strategic Interim Capital Empowers National Rollout, Managed Care Industry Entrance Boulder, CO, - Sept. 28, 2021

Withdrawal of offering statement [Regulation A] - Aug. 17, 2021

TransBiotec, Inc. Just Filed Its Quarterly Report: Basic net loss per s... - Aug. 16, 2021

Offering Statement [Regulation A] - July 20, 2021

TransBiotec, Inc. insider just disposed of 500 shares - July 6, 2021

Statement of changes in beneficial ownership of securities - June 30, 2021

Offering Statement [Regulation A] - June 17, 2021

TransBiotec, Inc. insider just disposed of 1,000 shares - May 18, 2021

TransBiotec, Inc. Just Filed Its Quarterly Report: The Company has eval... - May 17, 2021

Notice of Exempt Offering of Securities, item 06b - April 30, 2021

Statement of changes in beneficial ownership of securities - April 28, 2021

Offering Statement [Regulation A] - April 16, 2021

Annual report [Section 13 and 15(d), not S-K Item 405] - March 31, 2021

Unregistered Sales of Equity - Jan. 6, 2021

TransBiotec, Inc. director just declared owning 25,482 shares of TransBiotec, Inc. - Dec. 31, 2020

Major owner of TransBiotec, Inc. just picked up 5,846,197 shares - Dec. 31, 2020

Sorry, no schedule available for this company

 


Feedback